Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia

In chronic lymphocytic leukemia (CLL), the worst prognosis is associated with TP53 defects with the affected patients being potentially directed to alternative treatment. Therapy administration was shown to drive the selection of new TP53 mutations in CLL. Using ultra-deep next-generation sequencing...

Descripción completa

Detalles Bibliográficos
Autores principales: Malcikova, J, Stano-Kozubik, K, Tichy, B, Kantorova, B, Pavlova, S, Tom, N, Radova, L, Smardova, J, Pardy, F, Doubek, M, Brychtova, Y, Mraz, M, Plevova, K, Diviskova, E, Oltova, A, Mayer, J, Pospisilova, S, Trbusek, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396398/
https://www.ncbi.nlm.nih.gov/pubmed/25287991
http://dx.doi.org/10.1038/leu.2014.297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396398/
https://www.ncbi.nlm.nih.gov/pubmed/25287991
http://dx.doi.org/10.1038/leu.2014.297

Ejemplares similares